| 000 | 01632 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517104536.0 | ||
| 264 | 0 | _c20170906 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1938-3673 | ||
| 024 | 7 |
_a10.1189/jlb.4A0915-422R _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShasha, David | |
| 245 | 0 | 0 |
_aElite controller CD8+ T cells exhibit comparable viral inhibition capacity, but better sustained effector properties compared to chronic progressors. _h[electronic resource] |
| 260 |
_bJournal of leukocyte biology _c12 2016 |
||
| 300 |
_a1425-1433 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aCryopreservation |
| 650 | 0 | 4 | _aCytotoxicity, Immunologic |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aHIV _ximmunology |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-15 _xpharmacology |
| 650 | 0 | 4 | _aT-Cell Antigen Receptor Specificity |
| 650 | 0 | 4 |
_aT-Lymphocyte Subsets _ximmunology |
| 650 | 0 | 4 | _aVirus Replication |
| 700 | 1 | _aKarel, Dan | |
| 700 | 1 | _aAngiuli, Olivia | |
| 700 | 1 | _aGreenblatt, Adam | |
| 700 | 1 | _aGhebremichael, Musie | |
| 700 | 1 | _aYu, Xu | |
| 700 | 1 | _aPorichis, Filippos | |
| 700 | 1 | _aWalker, Bruce D | |
| 773 | 0 |
_tJournal of leukocyte biology _gvol. 100 _gno. 6 _gp. 1425-1433 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1189/jlb.4A0915-422R _zAvailable from publisher's website |
| 999 |
_c26218565 _d26218565 |
||